Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

600.00p
   
  • Change Today:
    -14.00p
  • 52 Week High: 1,545.00p
  • 52 Week Low: 130.00p
  • Currency: UK Pounds
  • Shares Issued: 5.92m
  • Volume: 30,254
  • Market Cap: £35.51m
  • RiskGrade: 340

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £1,126,362
Vladislav Sandler Ph.D. 103,862 £623,172
Peter Redmond 13,991 £83,946

Major Shareholders

Notifier** Holding Value*
Alexis Sandler 187,726 £1,126,356
David John Smith 143,594 £861,564
Dr Vladislav Sandler 103,862 £623,172
Optiva Securities Limited 70,329 £421,974
Flascherberg Capital Anstalt 69,991 £419,946
Craig Auringer 59,593 £357,558
HSBC Client Holdings Nominee (UK) Limited 45,160 £270,960
Ron Valk 42,828 £256,968
Samantha Bauer 42,706 £256,236
Plum Capital 29,232 £175,392
43 North LLC 28,429 £170,574
Abdelatif LACHAB 6,500 £39,000
Wayne Gibson 6,500 £39,000

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 600.00p
Change Today -14.00p
% Change -2.28 %
52 Week High 1,545.00p
52 Week Low 130.00p
Volume 30,254
Shares Issued 5.92m
Market Cap £35.51m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 02-Dec-2025

Time Volume / Share Price
16:36 4,000 @ 585.00p
13:29 13,000 @ 614.50p
16:29 46 @ 589.90p
16:29 100 @ 589.90p
16:26 240 @ 589.90p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page